Eli Lilly
Investor profile
Venture capital
Deals
2
distinct rounds
Companies
2
backed
Active span
2024–2025
2 yrs
Total round €
€102M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Orbis Medicines | Denmark | 1 | €90M |
| NanoSyrinx | UK | 1 | €12M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Orbis Medicines | Series A | €90M | 2025-01 |
| NanoSyrinx | Other | €12M | 2024-09 |